Brain shrinkage biomarker may predict early-onset Alzheimer’s progression
In people diagnosed with early-onset Alzheimer’s disease, a biomarker tool that detects shrinkage of the brain’s gray matter…
Scientists compared 51 longevity studies to see which aging biomarkers respond most reliably
A large-scale comparison of human longevity studies reveals why some epigenetic clocks detect biological changes far more consistently…
Later-life estrogen therapy associated with lower risk of developing dementia
Use of hormone therapy later in life was associated with lower risk of developing dementia, according to a…
Lab-grown mini tumors help scientists predict breast cancer treatment success
Researchers at UC San Francisco have developed a new method to predict how different types of breast cancer…
Gut microbiome shifts may begin before Alzheimer’s symptoms appear
A new review traces how diet, gut bacteria, and their metabolites may intersect with the silent biological changes…
Bioresorbable sensor tracks deep-tissue lactate for over 10 days in animals
Researchers developed a fully bioresorbable sensor that continuously tracked deep-tissue lactate for more than 10 days in animal…
Amyloid beta misfolding predicts Alzheimer’s years before symptoms appear
Widely used Alzheimer’s biomarker P-tau 217 reliably detects the disease only at the clinical stage. The protein misfolding…
Smart ring continuously tracks multiple health biomarkers from finger sweat
Engineers at the University of California San Diego created a smart ring that simultaneously and continuously monitors up to…
Handheld breathalyzer enables precise monitoring of fat metabolism
Researchers from ETH Zurich have developed a portable measuring device that detects the metabolic marker acetone in breath…
New ctDNA blood test improves personalized prostate cancer treatment
A noninvasive DNA blood test can identify metastatic castration-resistant prostate cancer (mCRPC) patients who are most likely to…
Blood p-tau217 levels signal cognitive impairment risk years before symptoms emerge
A six-cohort analysis links higher baseline p-tau217 to rising 5- and 10-year risks, bringing presymptomatic risk models closer…
LEAP2 hormone may predict anorexia nervosa relapse risk
People with anorexia nervosa have unusually high levels of a hormone called LEAP2 in their blood when they…